Vecamyl® (mecamylamine HCI) is indicated for the management of moderately severe to severe essential hypertension and in uncomplicated cases of malignant hypertension. To report a suspected adverse event or product complaint, or to submit a medical inquiry, please contact 1-800-769-8874 or email vecamylmedinfo@tildesciences.com